Home>Network News>UroToday: ASCO 2018 – SPEAR-Bladder (Study Informing Treatment Pathway Decision in Bladder Cancer): First-Through Third-Line Time to Treatment Failure in the US

UroToday: ASCO 2018 – SPEAR-Bladder (Study Informing Treatment Pathway Decision in Bladder Cancer): First-Through Third-Line Time to Treatment Failure in the US

Excellence in Cancer Care has a Network

As a national network of multi-specialty industry peers, we are dedicated to bringing innovation to local oncology care. We have the backing and resources to offer practices access to capital for expansion, innovative clinical trials through Sarah Cannon Research Institute, and the purchasing power and best-in-class contracting capabilities of Unity Group Purchasing Organization.

Join Our Network

Learn more about our commitment to enabling better cancer care through an integrated and supportive network that helps local practices maintain their independence and prosper.